Insider · CIK 0001222037

ADELMAN DANIEL C MD

Reports to the SEC for 2 companies · BRISBANE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001222037

Forms 4 and 5

Insider transactions

45 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-10-13	Aimmune Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−71.3K sh	$10.78	−$768K	0
2020-10-13	Aimmune Therapeutics, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−22.3K sh	$34.50	−$771K	0
2020-10-13	Aimmune Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−135K sh	$23.05	−$3.11M	0
2020-10-13	Aimmune Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−70K sh	$14.87	−$1.04M	0
2020-10-13	Aimmune Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−56.3K sh	$0.43	−$24.2K	0
2020-10-13	Aimmune Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−52.5K sh	$10.69	−$561K	0
2020-10-10	Aimmune Therapeutics, Inc.U Disposition from Tender	Chief Medical Officer	UDisposition from Tender	−41.5K sh	$34.50	−$1.43M	0
2020-10-02	Aimmune Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−34.9K sh	—	—	135,068
2020-10-02	Aimmune Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+34.9K sh	$11.45	+$400K	63,807
2020-09-15	Aimmune Therapeutics, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−840 sh	$34.25	−$28.8K	28,875
2020-05-10	Aimmune Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+2,420 sh	—	—	29,715
2020-03-02	Aimmune Therapeutics, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−1,872 sh	$23.81	−$44.6K	27,295
2020-02-28	Aimmune Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+8,750 sh	—	—	29,167
2020-02-28	Aimmune Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+52.5K sh	—	—	52,500
2020-01-02	Aimmune Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−20K sh	—	—	70,000
2020-01-02	Aimmune Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−20K sh	$35.00	−$700K	21,250
2020-01-02	Aimmune Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+20K sh	$19.63	+$393K	41,250
2019-12-09	Aimmune Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−20K sh	$30.04	−$601K	21,250
2019-12-09	Aimmune Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−20K sh	—	—	170,000
2019-12-09	Aimmune Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+20K sh	$11.45	+$229K	41,250
2019-03-01	Aimmune Therapeutics, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−833 sh	$24.30	−$20.2K	20,417
2019-02-22	Aimmune Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+71.3K sh	—	—	71,250
2019-02-22	Aimmune Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+11.9K sh	—	—	21,250
2018-03-04	Aimmune Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+9,375 sh	—	—	9,375
2018-03-04	Aimmune Therapeutics, Inc.Stock Option(right to buy)A Award	Chief Medical Officer	AAward	+56.3K sh	—	—	56,250
2018-01-16	Aimmune Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−9,933 sh	—	—	190,000
2018-01-16	Aimmune Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+9,933 sh	$11.45	+$114K	9,933
2018-01-16	Aimmune Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−9,933 sh	$40.00	−$397K	0
2018-01-12	Aimmune Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−26.8K sh	—	—	199,933
2018-01-12	Aimmune Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+26.8K sh	$11.45	+$307K	26,784
2018-01-12	Aimmune Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−26.8K sh	$40.00	−$1.07M	0
2017-12-27	Aimmune Therapeutics, Inc.Stock Option(right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,283 sh	—	—	226,717
2017-12-27	Aimmune Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−3,283 sh	$40.00	−$131K	0
2017-12-27	Aimmune Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,283 sh	$11.45	+$37.6K	3,283
2017-10-23	Aimmune Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−5,530 sh	$33.25	−$184K	4,470
2017-10-23	Aimmune Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−3,000 sh	$35.46	−$106K	0
2017-10-23	Aimmune Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−10K sh	—	—	230,000
2017-10-23	Aimmune Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+10K sh	$11.45	+$115K	10,000
2017-10-23	Aimmune Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,470 sh	$34.27	−$50.4K	3,000
2017-09-25	Aimmune Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+10K sh	$11.45	+$115K	10,000
2017-09-25	Aimmune Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−10K sh	—	—	240,000
2017-09-25	Aimmune Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−10K sh	$25.00	−$250K	0
2017-02-24	Aimmune Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+90K sh	—	—	90,000
2016-06-24	Aimmune Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+250K sh	—	—	250,000
2007-09-13	VIRXViracta Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Sr. VP, Development and CMO	AAward	+90K sh	—	—	90,000

Recent filings

Accepted (ET)
Oct 144
ADELMAN DANIEL C MD0000899243-20-028171
SEC(opens sec.gov)
Oct 54
ADELMAN DANIEL C MD0000899243-20-027460
SEC(opens sec.gov)
Sep 164
ADELMAN DANIEL C MD0000899243-20-025342
SEC(opens sec.gov)
May 124
ADELMAN DANIEL C MD0000899243-20-012850
SEC(opens sec.gov)
Mar 44
ADELMAN DANIEL C MD0000899243-20-007093
SEC(opens sec.gov)
Mar 34
ADELMAN DANIEL C MD0000899243-20-006851
SEC(opens sec.gov)
Feb 145
ADELMAN DANIEL C MD0000899243-20-004692
SEC(opens sec.gov)
Jan 34
ADELMAN DANIEL C MD0000899243-20-000395
SEC(opens sec.gov)
Dec 114
ADELMAN DANIEL C MD0000899243-19-028948
SEC(opens sec.gov)

Companies

Address

AIMMUNE THERAPEUTICS, INC. 8000 MARINA BOULEVARD, SUITE 300

BRISBANE, CA, 94005-1884